Endothelial c-REL orchestrates atherosclerosis at regions of disturbed flow through crosstalk with TXNIP-p38 and non-canonical NF-κB pathways
Cardiovascular Research · 23.05.2025 · 121 (5) · 748-759
DOI: 10.1093/cvr/cvaf024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 21.02.2025. Verfasst von Blanca Tardajos Ayllon und 12 weiteren Autor:innen. Beteiligte Einrichtung: William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK. Hauptthemen laut MEDLINE: Atherosclerosis, p38 Mitogen-Activated Protein Kinases, Carrier Proteins, NF-kappa B. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Medical Research Council.
Abstract (Originalsprache)
Aims
Atherosclerosis initiation at sites of disturbed blood flow involves heightened inflammation coupled to excessive endothelial cell (EC) proliferation. Here, we unveil the pivotal role of c-REL, a member of the NF-κB transcription factor family, in orchestrating these processes by driving dual pathological inflammatory and cell cycle pathways. Methods and results Analysis of cultured EC and murine models revealed enrichment and activation of c-REL at atherosusceptible sites experiencing disturbed flow. Transcriptome analysis, extensively validated in vitro and in vivo, demonstrates that endothelial c-REL drives inflammation via a TXNIP-p38 MAP kinase signalling pathway and enhances proliferation through a non-canonical NFKB2-p21 pathway. Consistent with its pivotal role in EC pathology, genetic deletion of c-Rel in EC significantly reduces plaque burden in hypercholesterolaemic mice.
Conclusion
These findings underscore the fundamental role of c-REL in endothelial responses to disturbed flow and highlight therapeutic targeting of endothelial c-REL as a potential strategy for atherosclerosis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
- School of Medicine and Population Health, INSIGNEO Institute, and the Bateson Centre, University of Sheffield, Sheffield, UK.
- Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
- Department of Endocrinology, Institute of Endocrine and Metabolic Disease, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei)…
- Bioscience Institute, Faculty of Medical Science, Newcastle University, Newcastle Upon Tyne, UK.
ORCID-Profile: Suowen Xu, Jovana Serbanovic-Canic, Paul Charles Evans
Förderung
- British Heart Foundation
- Medical Research Council
Zitieren
APA
Tardajos Ayllon, B., Bowden, N., Souilhol, C., Darwish, H., Tian, S., Duckworth, C., Pritchard, D. M., Xu, S., Sayers, J., Francis, S., Serbanovic-Canic, J., Oakley, F., & Evans, P. C. (2025). Endothelial c-REL orchestrates atherosclerosis at regions of disturbed flow through crosstalk with TXNIP-p38 and non-canonical NF-κB pathways. Cardiovascular Research, 121(5), 748-759. https://doi.org/10.1093/cvr/cvaf024
Vancouver
Tardajos Ayllon B, Bowden N, Souilhol C, Darwish H, Tian S, Duckworth C, et al. Endothelial c-REL orchestrates atherosclerosis at regions of disturbed flow through crosstalk with TXNIP-p38 and non-canonical NF-κB pathways. Cardiovascular Research. 2025;121(5):748-759. doi:10.1093/cvr/cvaf024
BibTeX
@article{TardajosAyllon2025,
author = {Tardajos Ayllon, Blanca and Bowden, Neil and Souilhol, Celine and Darwish, Hazem and Tian, Siyu and Duckworth, Carrie and Pritchard, David Mark and Xu, Suowen and Sayers, Jon and Francis, Sheila and Serbanovic-Canic, Jovana and Oakley, Fiona and Evans, Paul Charles},
title = {Endothelial c-REL orchestrates atherosclerosis at regions of disturbed flow through crosstalk with TXNIP-p38 and non-canonical NF-κB pathways},
journal = {Cardiovascular Research},
year = {2025},
volume = {121},
number = {5},
pages = {748--759},
doi = {10.1093/cvr/cvaf024}
}
EUVIMED